Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
Akebia Therapeutics, Inc. (AKBA)
| Date | Name | Title | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/06/2023 | ROGERS MICHAEL W | Director | Grant | Common Stock | 30k | $0.00 | $0 | | 06/06/2023 |
| 06/06/2023 | ROGERS MICHAEL W | Director | Grant | Stock Option (Right to buy) | 45k | $1.20 | $54k | | 06/06/2023 |
| 06/06/2023 | ZUMWALT LEANNE M | Director | Grant | Stock Option (Right to buy) | 45k | $1.20 | $54k | | 06/06/2023 |
| 06/06/2023 | ZUMWALT LEANNE M | Director | Grant | Common Stock | 30k | $0.00 | $0 | | 06/06/2023 |
| 06/06/2023 | GILMAN STEVEN C | Director | Grant | Common Stock | 30k | $0.00 | $0 | | 06/06/2023 |
| 06/06/2023 | GILMAN STEVEN C | Director | Grant | Stock Option (Right to buy) | 45k | $1.20 | $54k | | 06/06/2023 |
| 06/06/2023 | ADAMS ADRIAN | Director | Grant | Common Stock | 30k | $0.00 | $0 | | 06/06/2023 |
| 06/06/2023 | ADAMS ADRIAN | Director | Grant | Stock Option (Right to buy) | 45k | $1.20 | $54k | | 06/06/2023 |
| 06/06/2023 | Smith Cynthia | Director | Grant | Common Stock | 30k | $0.00 | $0 | | 06/06/2023 |
| 06/06/2023 | Smith Cynthia | Director | Grant | Stock Option (Right to buy) | 45k | $1.20 | $54k | | 06/06/2023 |
| 06/06/2023 | Wolf Myles | Director | Grant | Common Stock | 30k | $0.00 | $0 | | 06/06/2023 |
| 06/06/2023 | Wolf Myles | Director | Grant | Stock Option (Right to buy) | 45k | $1.20 | $54k | | 06/06/2023 |
| 06/06/2023 | FRIESON RON | Director | Grant | Common Stock | 30k | $0.00 | $0 | | 06/06/2023 |
| 06/06/2023 | FRIESON RON | Director | Grant | Stock Option (Right to buy) | 45k | $1.20 | $54k | | 06/06/2023 |
| 05/25/2023 | Hadas Nicole R. | SVP, Chief Legal Officer | Sale | Common Stock | 63.2k | $1.22 | $77.3k | | 05/24/2023 |
| 05/25/2023 | Dahan Michel | SVP, COO | Sale | Common Stock | 95.5k | $1.22 | $116.8k | | 05/24/2023 |
| 05/24/2023 | Dahan Michel | SVP, COO | Grant | Employee Stock Option (Right to buy) | 200k | $0.41 | $82k | | 05/24/2023 |
| 05/24/2023 | Dahan Michel | SVP, COO | Grant | Common Stock | 200k | $0.00 | $0 | | 05/24/2023 |
| 05/24/2023 | Hadas Nicole R. | SVP, Chief Legal Officer | Grant | Employee Stock Option (Right to buy) | 200k | $0.41 | $82k | | 05/24/2023 |
| 05/24/2023 | Hadas Nicole R. | SVP, Chief Legal Officer | Grant | Common Stock | 200k | $0.00 | $0 | | 05/24/2023 |
| 05/16/2023 | Spellman David A | SVP, CFO and Treasurer | Sale | Common Stock | 63.6k | $1.07 | $67.9k | | 05/16/2023 |
| 05/16/2023 | Burke Steven Keith | SVP, Chief Medical Officer | Sale | Common Stock | 63.6k | $1.07 | $67.9k | | 05/16/2023 |
| 05/12/2023 | Hadas Nicole R. | SVP, Chief Legal Officer | Grant | Common Stock | 100k | $0.00 | $0 | | 05/12/2023 |
| 05/12/2023 | Dahan Michel | SVP, COO | Grant | Common Stock | 200k | $0.00 | $0 | | 05/12/2023 |
| 03/01/2023 | Dahan Michel | SVP, COO | Sale | Common Stock | 8.1k | $0.88 | $7.1k | | 03/01/2023 |
| 03/01/2023 | Dahan Michel | SVP, COO | Sale | Common Stock | 10.5k | $0.88 | $9.2k | | 03/01/2023 |
| 03/01/2023 | Dahan Michel | SVP, COO | Sale | Common Stock | 1.9k | $0.88 | $1.6k | | 03/01/2023 |
| 03/01/2023 | Hadas Nicole R. | SVP, Chief Legal Officer | Sale | Common Stock | 5.3k | $0.88 | $4.7k | | 03/01/2023 |
| 03/01/2023 | Hadas Nicole R. | SVP, Chief Legal Officer | Sale | Common Stock | 6.6k | $0.88 | $5.8k | | 03/01/2023 |
| 03/01/2023 | Hadas Nicole R. | SVP, Chief Legal Officer | Sale | Common Stock | 1.1k | $0.88 | $954.7 | | 03/01/2023 |
| 03/01/2023 | Butler John P. | CEO and President | Sale | Common Stock | 38.3k | $0.88 | $33.6k | | 03/01/2023 |
| 03/01/2023 | Butler John P. | CEO and President | Sale | Common Stock | 47.2k | $0.88 | $41.5k | | 03/01/2023 |
| 03/01/2023 | Butler John P. | CEO and President | Sale | Common Stock | 6.4k | $0.88 | $5.6k | | 03/01/2023 |
| 03/01/2023 | Burke Steven Keith | SVP, Chief Medical Officer | Sale | Common Stock | 6.6k | $0.88 | $5.8k | | 03/01/2023 |
| 03/01/2023 | Burke Steven Keith | SVP, Chief Medical Officer | Sale | Common Stock | 6.4k | $0.88 | $5.6k | | 03/01/2023 |
|
|